Department of Physiology, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
Research and Development, Orion Corporation Orion Pharma, 20101 Turku, Finland.
Int J Mol Sci. 2022 Jun 14;23(12):6629. doi: 10.3390/ijms23126629.
Netrin-1, a chemoattractant expressed by floor plate cells, and one of its receptors (deleted in colorectal cancer) has been associated with pronociceptive actions in a number of pain conditions. Here, we addressed the question of whether spinal TRPC4/C5 or TRPA1 are among the downstream receptors contributing to pronociceptive actions induced by netrin-1. The experiments were performed on rats using a chronic intrathecal catheter for administration of netrin-1 and antagonists of TRPC4/C5 or TRPA1. Pain sensitivity was assessed behaviorally by using mechanical and heat stimuli. Effect on the discharge rate of rostral ventromedial medullary (RVM) pain control neurons was studied in lightly anesthetized animals. Netrin-1, in a dose-related fashion, induced mechanical hypersensitivity that lasted up to three weeks. Netrin-1 had no effect on heat nociception. Mechanical hypersensitivity induced by netrin-1 was attenuated by TRPA1 antagonist Chembridge-5861528 and by the control analgesic compound pregabalin both during the early (first two days) and late (third week) phase of hypersensitivity. TRPC4/C5 antagonist ML-204 had a weak antihypersensitivity effect that was only in the early phase, whereas TRPC4/C5 antagonist HC-070 had no effect on hypersensitivity induced by netrin-1. The discharge rate in pronociceptive ON-like RVM neurons was increased by netrin-1 during the late but not acute phase, whereas netrin-1 had no effect on the discharge rate of antinociceptive RVM OFF-like neurons. The results suggest that spinal TRPA1 receptors and pronociceptive RVM ON-like neurons are involved in the maintenance of submodality-selective pronociceptive actions induced by netrin-1 in the spinal cord.
轴突导向因子 Netrin-1 是一种由基板细胞表达的趋化因子,其受体之一(结直肠癌缺失)与多种疼痛状况下的致痛作用有关。在这里,我们研究了脊髓 TRPC4/C5 或 TRPA1 是否是 Netrin-1 诱导的致痛作用的下游受体之一。实验在大鼠中进行,使用慢性鞘内导管给予 Netrin-1 和 TRPC4/C5 或 TRPA1 的拮抗剂。使用机械和热刺激通过行为评估疼痛敏感性。在轻度麻醉动物中研究了对延髓头端腹内侧(RVM)痛觉控制神经元放电率的影响。Netrin-1 以剂量相关的方式诱导机械性超敏反应,持续长达三周。Netrin-1 对热痛觉无影响。TRPA1 拮抗剂 Chembridge-5861528 和对照镇痛化合物普瑞巴林均可减轻 Netrin-1 诱导的机械性超敏反应,无论是在早期(前两天)还是晚期(第三周)超敏反应阶段。TRPC4/C5 拮抗剂 ML-204 仅在早期具有较弱的抗超敏作用,而 TRPC4/C5 拮抗剂 HC-070 对 Netrin-1 诱导的超敏反应没有影响。在晚期但不在急性阶段,Netrin-1 增加了致痛性 ON 样 RVM 神经元的放电率,而 Netrin-1 对镇痛性 RVM OFF 样神经元的放电率没有影响。结果表明,脊髓 TRPA1 受体和致痛性 RVM ON 样神经元参与维持 Netrin-1 在脊髓中诱导的亚模态选择性致痛作用。